Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-9545 Following a Single Oral Dose (Part 1) and to Evaluate the Absolute and Relative Bioavailability of Oral Capsule Formulations of GDC-9545 (Part 2) in Healthy Female Subjects of Non-Childbearing Potential

NCT04680273 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: [14C]-GDC-9545
DRUG: GDC-9545 Solution for Infusion
DRUG: GDC-9545/F12 Capsule
DRUG: GDC-9545/F18 Capsule

Sponsor

Genentech, Inc.